News about "Drug Development"

Nimbus Therapeutics Hits Preclinical Research Milestone with Lilly

Throughout their collaboration, Nimbus has leveraged its computational approaches and structure-based drug design capabilities to help overcome these historical obstacles.

Drug Development | 26/02/2025 | By Aishwarya

Hoth Therapeutics Announces Acquisition of New Patent Applications

Hoth Therapeutics continues to invest in robust research and development strategies, ensuring the protection and growth of its proprietary technologies.

Drug Development | 22/01/2025 | By Aishwarya

VectorY Welcomes Jim Scibetta as New CEO

Scibetta brings more than 20 years of executive leadership experience, having built earlier stage companies focused on developing novel therapeutics for high unmet medical needs into mature biotechnology companies.

Drug Development | 17/12/2024 | By Aishwarya |  114

Samsung Biologics Develops High-Concentration Formulation Platform for Drug Development

S-HiCon can proactively identify unintended pH changes, enhance formulation stability, and reduce viscosity to ensure efficacy and maximize drug delivery.

Drug Development | 15/10/2024 | By Aishwarya |  156

BioMarin Strengthens its Leadership with New Appointments

At BioMarin, he will assume responsibility for the company's R&D organization, including discovery research, preclinical, translational and clinical programs, as well as global regulatory and medical affairs.

Drug Development | 22/08/2024 | By Aishwarya |  194

Gericke Unveils GSF Lab System for Drug Development

Gericke has rolled out GFS LAB for continuous manufacturing of formulation development for drug development.

Drug Development | 12/07/2024 | By Aishwarya |  223

Selvita Acquires PozLab to Expand its Drug Development Capabilities

Selvita has completed a strategic transaction in which it has acquired 100% of shares in PozLab.

Drug Development | 08/05/2024 | By Aishwarya |  197

FDA Inaugurates CDER Center for Clinical Trial Innovation (C3TI)

FDA's Center for Drug Evaluation and Research (CDER) has launched the CDER Center for Clinical Trial Innovation (C3TI).

Drug Development | 16/04/2024 | By Aishwarya |  215

Athira Pharma Announces Appointment of Javier San Martin as Chief Medical Officer

Athira Pharma, Inc. has appointed Javier San Martin, MD, as Chief Medical Officer.

Drug Development | 16/04/2024 | By Aishwarya |  258

Cadenza Bio Welcomes Michael A. Panzara to its Board of Directors

Cadenza Bio, Inc. has appointed Michael A. Panzara, MD, MPH, to its esteemed board of directors.

Drug Development | 04/04/2024 | By Aishwarya |  312